{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:46:28Z","timestamp":1781880388281,"version":"3.54.5"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T00:00:00Z","timestamp":1389830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s40620-013-0028-x","type":"journal-article","created":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T04:19:58Z","timestamp":1389759598000},"page":"103-106","source":"Crossref","is-referenced-by-count":39,"title":["Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy"],"prefix":"10.1093","volume":"27","author":[{"given":"Choli","family":"Hartono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng F.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya V.","family":"Seshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thangamani","family":"Muthukumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,1,16]]},"reference":[{"key":"28_CR1","author":"C Ponticelli","year":"2013","unstructured":"Ponticelli C, Glassock RJ (2013) Glomerular diseases: membranous nephropathy\u2014a modern view. Clin J Am Soc Nephrol. doi: 10.2215\/CJN.04160413","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"28_CR2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1681\/ASN.2009080861","volume":"21","author":"N Polanco","year":"2010","unstructured":"Polanco N, Gutierrez E, Covarsi A et al (2010) Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol 21(4):697\u2013704","journal-title":"J Am Soc Nephrol"},{"key":"28_CR3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ki.1997.127","volume":"51","author":"DC Cattran","year":"1997","unstructured":"Cattran DC, Pei Y, Greenwood CM et al (1997) Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int 51:901\u2013907","journal-title":"Kidney Int"},{"key":"28_CR4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/kisup.2012.9","volume":"2","author":"Kidney Disease Improving Global Outcomes","year":"2012","unstructured":"Kidney Disease Improving Global Outcomes (2012) KDIGO clinical practice guidelines for glomerulonephritis. Kidney Int 2:139\u2013172","journal-title":"Kidney Int"},{"key":"28_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck","year":"2009","unstructured":"Beck LH, Bonegio RGB, Lambeau G et al (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11\u201321","journal-title":"N Engl J Med"},{"key":"28_CR6","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2215\/CJN.02170312","volume":"7","author":"C Murtas","year":"2012","unstructured":"Murtas C, Bruschi M, Candiano G et al (2012) Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin J Am Soc Nephrol 7:1394\u20131400","journal-title":"Clin J Am Soc Nephrol"},{"key":"28_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM198901053200102","volume":"320","author":"C Ponticelli","year":"1989","unstructured":"Ponticelli C, Zucchelli P, Passerini P et al (1989) A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 320:8\u201313","journal-title":"N Engl J Med"},{"key":"28_CR8","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(12)61566-9","volume":"381","author":"A Howman","year":"2013","unstructured":"Howman A, Chapman TL, Langdon MM et al (2013) Immunosuppression for progressive membranous nephropathy: a UK randomized controlled trial. Lancet 381:744\u2013751","journal-title":"Lancet"},{"key":"28_CR9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1056\/NEJMc1213206","volume":"368","author":"J Shortt","year":"2013","unstructured":"Shortt J, Oh DH, Opat SS (2013) ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura. N Engl J Med 368:90\u201392","journal-title":"N Engl J Med"},{"key":"28_CR10","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/ndt\/gfm351","volume":"22","author":"T Forslund","year":"2007","unstructured":"Forslund T, Sikio A, Anttinen J (2007) IgA nephropathy in a patient with IgG lambda light-chain plasmacytoma: a rare coincidence. Nephrol Dial Transplant 22:2705\u20132708","journal-title":"Nephrol Dial Transplant"},{"key":"28_CR11","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1681\/ASN.2012020181","volume":"23","author":"P Ruggenenti","year":"2012","unstructured":"Ruggenenti P, Cravedi P, Chianca A et al (2012) Rituximab in idiopathic membranous nephropathy. J Am Soc Nephrol 23:1416\u20131425","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"28_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","volume":"9","author":"DK Perry","year":"2009","unstructured":"Perry DK, Burns JM, Pollinger HS et al (2009) Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production. Am J Transplant 9(1):201\u2013209","journal-title":"Am J Transplant"},{"key":"28_CR13","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2010111125","volume":"22","author":"LH Beck Jr","year":"2011","unstructured":"Beck LH Jr, Fervenza FC, Beck DM et al (2011) Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 22:1543\u20131550","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-013-0028-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-013-0028-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-013-0028-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:50Z","timestamp":1777564670000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/27\/1\/103\/8372196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,16]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1007\/s40620-013-0028-x","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,16]]}}}